Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Axel H. Schönthal
Multitarget Inhibition of Drug-Resistant Multiple Myeloma Cell Lines by Dimethyl-Celecoxib (DMC), a Non-Cox-2 Inhibitory Analog of Celecoxib
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Related publications
Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines
Journal of Surgical Research
Surgery
Antitumor Effects of Celecoxib in COX-2 Expressing and Non-Expressing Canine Melanoma Cell Lines
Research in Veterinary Science
Veterinary
Inhibition Mechanism of the Intracellular Transporter Ca2+-Pump From Sarco-Endoplasmic Reticulum by the Antitumor Agent Dimethyl-Celecoxib
PLoS ONE
Multidisciplinary
Curcumol Potentiates Celecoxib-Induced Growth Inhibition and Apoptosis in Human Non-Small Cell Lung Cancer
Oncotarget
Oncology
Erratum To: Preventive Effects of COX-2 Inhibitor, Celecoxib on Renal Tubular Injury Induced by Shock Wave Lithotriptor
Urological Research
Combination of Celecoxib and PD184161 Exerts Synergistic Inhibitory Effects on Gallbladder Cancer Cell Proliferation
Oncology Letters
Cancer Research
Oncology
Risk of Gastrointestinal Effects With COX-2 Inhibitors and NSAIDs: Study Conclusions Do Not Reflect Findings for Celecoxib
BMJ
Celecoxib Induced Bullous Eruption Confirmed by a Patch Test
Clinical and Translational Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Risk of Gastrointestinal Effects With COX-2 Inhibitors and NSAIDs: What Does Evidence From Randomised Trials Show About Celecoxib?
BMJ